{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:02:37Z","timestamp":1789056157690,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471955"],"award-info":[{"award-number":["82471955"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.acra.2025.11.008","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T12:15:47Z","timestamp":1764159347000},"page":"556-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Association of Enlarged Perivascular Space with Cerebrospinal Fluid GFAP in Early Parkinson\u2019s Disease"],"prefix":"10.1016","volume":"33","author":[{"given":"Qiuyue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7055-993X","authenticated-orcid":false,"given":"Meihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2025.11.008_bib1","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.acra.2025.11.008_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/nan.12298","article-title":"Review: Sporadic Parkinson\u2019s disease: development and distribution of a-synuclein pathology","volume":"42","author":"Del Tredici","year":"2016","journal-title":"Neuropathol\u00a0Appl Neurobio"},{"key":"10.1016\/j.acra.2025.11.008_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson\u2019s disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.acra.2025.11.008_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-019-0147-y","article-title":"Blocking meningeal lymphatic drainage aggravates Parkinson\u2019s disease-like pathology in mice overexpressing mutated \u03b1-synuclein","volume":"8","author":"Zou","year":"2019","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.acra.2025.11.008_bib5","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s12035-023-03212-2","article-title":"Interaction between the glymphatic system and \u03b1-synuclein in Parkinson\u2019s disease","volume":"60","author":"Zhang","year":"2023","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.acra.2025.11.008_bib6","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.4103\/1673-5374.390970","article-title":"Interplay between the glymphatic system and neurotoxic proteins in Parkinson\u2019s disease and related disorders: current knowledge and future directions","volume":"19","author":"Yue","year":"2023","journal-title":"Neural Regen\u00a0Res"},{"key":"10.1016\/j.acra.2025.11.008_bib7","first-page":"249","article-title":"Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol\u00a0Dis"},{"key":"10.1016\/j.acra.2025.11.008_bib8","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3390\/biom12121745","article-title":"A focus on astrocyte contribution to Parkinson\u2019s disease etiology","volume":"12","author":"Prunell","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.acra.2025.11.008_bib9","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci\u00a0Transl\u00a0Med"},{"key":"10.1016\/j.acra.2025.11.008_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41582-020-0312-z","article-title":"Perivascular spaces in the brain: anatomy, physiology and pathology","volume":"16","author":"Wardlaw","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.acra.2025.11.008_bib11","article-title":"New perspectives on the glymphatic system and the relationship between glymphatic system and neurodegenerative diseases","volume":"205","author":"Sun","year":"2025","journal-title":"Neurobiol\u00a0Dis"},{"key":"10.1016\/j.acra.2025.11.008_bib12","first-page":"289","article-title":"Imaging the perivascular space as a potential biomarker of neurovascular and neurodegenerative diseases","volume":"36","author":"Ramirez","year":"2016","journal-title":"Cell\u00a0Mol\u00a0Neurobiol"},{"key":"10.1016\/j.acra.2025.11.008_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00415-023-12004-6","article-title":"Correlation of glymphatic system abnormalities with Parkinson\u2019s disease progression: a clinical study based on non-invasive fMRI","volume":"271","author":"Meng","year":"2024","journal-title":"J. Neurol"},{"key":"10.1016\/j.acra.2025.11.008_bib14","first-page":"2257","article-title":"Perivascular spaces, glymphatic dysfunction, and small vessel disease","volume":"131","author":"Mestre","year":"2017","journal-title":"Clin\u00a0Sci"},{"key":"10.1016\/j.acra.2025.11.008_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41531-022-00437-1","article-title":"Diffusion along perivascular spaces as marker for impairment of glymphatic system in Parkinson\u2019s disease","volume":"8","author":"Shen","year":"2022","journal-title":"npj Parkinson\u2019s Dis."},{"key":"10.1016\/j.acra.2025.11.008_bib16","first-page":"1126","article-title":"Global and regional changes in perivascular space in idiopathic and familial Parkinson\u2019s disease","volume":"36","author":"Donahue","year":"2021","journal-title":"Mov\u00a0Disord"},{"key":"10.1016\/j.acra.2025.11.008_bib17","first-page":"1314","article-title":"Glymphatic system impairment in Alzheimer\u2019s disease: associations with perivascular space volume and cognitive function","volume":"34","author":"Zhang","year":"2023","journal-title":"Eur\u00a0Radiol"},{"key":"10.1016\/j.acra.2025.11.008_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41531-021-00155-0","article-title":"The role of brain perivascular space burden in early-stage Parkinson\u2019s disease","volume":"7","author":"Shen","year":"2021","journal-title":"npj Parkinsons Dis"},{"key":"10.1016\/j.acra.2025.11.008_bib19","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209483","article-title":"Regional burden of enlarged perivascular spaces and cognition and neuropsychiatric symptoms in drug-naive patients with Parkinson disease","volume":"102","author":"Kim","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.acra.2025.11.008_bib20","article-title":"T2 MRI visible perivascular spaces in parkinson\u2019s disease: clinical significance and association with polysomnography measured sleep","author":"Meinhold","year":"2024","journal-title":"Sleep"},{"key":"10.1016\/j.acra.2025.11.008_bib21","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/glia.23734","article-title":"Neurochemical regulation of the expression and function of glial fibrillary acidic protein in astrocytes","volume":"68","author":"Li","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.acra.2025.11.008_bib22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","article-title":"Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker","volume":"38","author":"Yang","year":"2015","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.acra.2025.11.008_bib23","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuron.2020.08.012","article-title":"Astrocyte crosstalk in CNS inflammation","volume":"108","author":"Linnerbauer","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.acra.2025.11.008_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/neur.1996.0020","article-title":"Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson\u2019s disease mice model","volume":"5","author":"Cz\u0142onkowska","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.acra.2025.11.008_bib25","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.acra.2025.11.008_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/antiox8080265","article-title":"Astrocytic oxidative\/nitrosative stress contributes to Parkinson\u2019s disease pathogenesis: the dual role of reactive astrocytes","volume":"8","author":"Rizor","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.acra.2025.11.008_bib27","first-page":"6295","article-title":"Tau, glial fibrillary acidic protein, and neurofilament light chain as brain protein biomarkers in cerebrospinal fluid and blood for diagnosis of neurobiological diseases","volume":"25","author":"Park","year":"2024","journal-title":"Int\u00a0J\u00a0Mol\u00a0Sci"},{"key":"10.1016\/j.acra.2025.11.008_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257372","article-title":"Biomarkers of neurodegeneration and glial activation validated in Alzheimer\u2019s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson\u2019s disease","volume":"16","author":"Bartl","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.acra.2025.11.008_bib29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.acra.2025.11.008_bib30","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.3390\/ijms22147491","article-title":"The glymphatic system (en)during inflammation","volume":"22","author":"Mogensen","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.acra.2025.11.008_bib31","article-title":"The relationship between inflammation, impaired glymphatic system, and neurodegenerative disorders: a vicious cycle","volume":"192","author":"Cai","year":"2024","journal-title":"Neurobiol\u00a0Dis"},{"key":"10.1016\/j.acra.2025.11.008_bib32","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/cells13030286","article-title":"Glymphatic system pathology and neuroinflammation as two risk factors of neurodegeneration","volume":"13","author":"Szlufik","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.acra.2025.11.008_bib33","article-title":"OAB-14 attenuated glymphatic system disorder, neuroinflammation and dyskinesia in Parkinson\u2019s disease model mice induced by rotenone","volume":"50","author":"Zhao","year":"2025","journal-title":"Neurochem\u00a0Res"},{"key":"10.1016\/j.acra.2025.11.008_bib34","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/STROKEAHA.109.564914","article-title":"Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease","volume":"41","author":"Doubal","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.acra.2025.11.008_bib35","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1474-4422(23)00131-X","article-title":"Neuroimaging standards for research into small vessel disease\u2014advances since 2013","volume":"22","author":"Duering","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.acra.2025.11.008_bib36","first-page":"1672","article-title":"Magnetic resonance imaging\u2013visible perivascular spaces in basal ganglia predict cognitive decline in Parkinson\u2019s disease","volume":"34","author":"Park","year":"2019","journal-title":"Mov\u00a0Disord"},{"key":"10.1016\/j.acra.2025.11.008_bib37","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.3390\/jcm11236964","article-title":"Research evidence of the role of the glymphatic system and its potential pharmacological modulation in neurodegenerative diseases","volume":"11","author":"Verghese","year":"2022","journal-title":"JCM"},{"key":"10.1016\/j.acra.2025.11.008_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2022.105254","article-title":"Noninvasive neuroimaging provides evidence for deterioration of the glymphatic system in Parkinson\u2019s disease relative to essential tremor","volume":"107","author":"Gu","year":"2023","journal-title":"Parkinsonism Related Disord"},{"key":"10.1016\/j.acra.2025.11.008_bib39","first-page":"161","article-title":"Dilated perivascular space in the midbrain may reflect dopamine neuronal degeneration in Parkinson\u2019s disease","volume":"12","author":"Li","year":"2020","journal-title":"Front\u00a0Aging Neurosci"},{"key":"10.1016\/j.acra.2025.11.008_bib40","first-page":"1953","article-title":"Changes of cerebrospinal fluid A\u03b242, t-tau, and p-tau in parkinson\u2019s disease patients with cognitive impairment relative to those with normal cognition: a meta-analysis","volume":"38","author":"Hu","year":"2017","journal-title":"Neurol\u00a0Sci"},{"key":"10.1016\/j.acra.2025.11.008_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jpsychires.2025.05.038","article-title":"Depressive symptoms interact with CSF levels of p-tau in predicting cognitive performance in the early stages of parkinson\u2019s disease","volume":"188","author":"Jauregi-Zinkunegi","year":"2025","journal-title":"J\u00a0Psychiatr\u00a0Res"},{"key":"10.1016\/j.acra.2025.11.008_bib42","first-page":"573","article-title":"CSF phospho-tau levels at Parkinson\u2019s disease onset predict the risk for development of motor complications","volume":"272","author":"Bissacco","year":"2025","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.acra.2025.11.008_bib43","first-page":"2874","article-title":"Systematic assessment of 10 biomarker candidates focusing on \u03b1-synuclein-related disorders","volume":"36","author":"Schulz","year":"2021","journal-title":"Mov\u00a0Disord"},{"key":"10.1016\/j.acra.2025.11.008_bib44","first-page":"5461","article-title":"Associations of Alzheimer\u2019s-related plasma biomarkers with cognitive decline in Parkinson\u2019s disease","volume":"270","author":"Mizutani","year":"2023","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.acra.2025.11.008_bib45","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3233\/JAD-180325","article-title":"Glial fibrillary acidic protein in serum is increased in Alzheimer\u2019s disease and correlates with cognitive impairment","volume":"67","author":"Oeckl","year":"2019","journal-title":"J\u00a0Alzheimer\u2019s Dis"},{"key":"10.1016\/j.acra.2025.11.008_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41531-023-00447-7","article-title":"Plasma GFAP in Parkinson\u2019s disease with cognitive impairment and its potential to predict conversion to dementia","volume":"9","author":"Tang","year":"2023","journal-title":"npj Parkinsons Dis"},{"key":"10.1016\/j.acra.2025.11.008_bib47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/biom12020329","article-title":"Update on CSF biomarkers in Parkinson\u2019s disease","volume":"12","author":"Kwon","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.acra.2025.11.008_bib48","first-page":"5217","article-title":"Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson\u2019s disease biomarkers using multiplexed single molecule counting","volume":"13","author":"Youssef","year":"2023","journal-title":"Sci\u00a0Rep"},{"key":"10.1016\/j.acra.2025.11.008_bib49","doi-asserted-by":"crossref","DOI":"10.1186\/s12987-023-00429-0","article-title":"A year in review: brain barriers and brain fluids research in 2022","volume":"20","author":"Keep","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.acra.2025.11.008_bib50","article-title":"Current concepts in intracranial interstitial fluid transport and the glymphatic system: Part I\u2014anatomy and physiology","author":"Klostranec","year":"2021","journal-title":"Radiology"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633225010608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633225010608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:06:49Z","timestamp":1773932809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633225010608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1076633225010608"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2025.11.008","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Association of Enlarged Perivascular Space with Cerebrospinal Fluid GFAP in Early Parkinson\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2025.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Association of Academic Radiology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}